Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DNLI Denali Therapeutics Inc.	$1.98B	$0 0.0% of portfolio	0	Q4 2024 New
DRMA Dermata Therapeutics, Inc.	$11.9M	$0 0.0% of portfolio	0	Q4 2024 New
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 0.0% of portfolio	0	Q4 2024 New
DSGN Design Therapeutics, Inc.	$235M	$0 0.0% of portfolio	0	Q4 2024 New
DMAC Dia Medica Therapeutics Inc.	$101M	$0 0.0% of portfolio	0	Q4 2024 New
DYAI Dyadic International Inc	$38.9M	$0 0.0% of portfolio	0	Q4 2024 New
DYN Dyne Therapeutics, Inc.	$593M	$0 0.0% of portfolio	0	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.47B	$0 0.0% of portfolio	0	Q4 2024 New
EDIT Editas Medicine, Inc.	$85.9M	$0 0.0% of portfolio	75	Q3 2023 Reduced 92.79%
ELDN Eledon Pharmaceuticals, Inc.	$46.1M	$0 0.0% of portfolio	0	Q4 2024 New
ELEV Elevation Oncology, Inc.	$6.06M	$0 0.0% of portfolio	0	Q4 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$0 0.0% of portfolio	0	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$118M	$0 0.0% of portfolio	0	Q4 2024 New
ENLV Enlivex Therapeutics Ltd.	$18.8M	$0 0.0% of portfolio	0	Q4 2024 New
ENOB Enochian Biosciences Inc	$244M	$0 0.0% of portfolio	0	Q4 2024 New
ENTX Entera Bio Ltd.	$50.4M	$0 0.0% of portfolio	0	Q4 2024 New
TRDA Entrada Therapeutics, Inc.	$300M	$0 0.0% of portfolio	0	Q4 2024 New
EQ Equillium, Inc.	$14.1M	$0 0.0% of portfolio	0	Q4 2024 New
ERAS Erasca, Inc.	$186M	$0 0.0% of portfolio	0	Q4 2024 New
EPIX Essa Pharma Inc.	$69.2M	$0 0.0% of portfolio	0	Q4 2024 New
ETON Eton Pharmaceuticals, Inc.	$329M	$0 0.0% of portfolio	0	Q4 2024 New
EYEN Eyenovia, Inc.	$38.7M	$0 0.0% of portfolio	0	Q4 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$199M	$0 0.0% of portfolio	0	Q4 2024 New
FSTX F Star Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
FATE Fate Therapeutics Inc	$82.5M	$0 0.0% of portfolio	0	Q4 2024 New
FENC Fennec Pharmaceuticals Inc.	$169M	$0 0.0% of portfolio	0	Q4 2024 New
FGEN Fibrogen Inc	$29.1M	$0 0.0% of portfolio	0	Q4 2024 New
FWBI First Wave Bio Pharma, Inc.	$2.54M	$0 0.0% of portfolio	0	Q4 2024 New
FHTX Foghorn Therapeutics Inc.	$147M	$0 0.0% of portfolio	0	Q4 2024 New
FULC Fulcrum Therapeutics, Inc.	$157M	$0 0.0% of portfolio	0	Q4 2024 New
GANX Gain Therapeutics, Inc.	$22.5M	$0 0.0% of portfolio	0	Q4 2024 New
GLPG Galapagos Nv	$1.68B	$0 0.0% of portfolio	0	Q4 2024 New
GALT Galectin Therapeutics Inc	$90.3M	$0 0.0% of portfolio	0	Q4 2024 New
GNTA Genenta Science S.P.A.	$72.3M	$0 0.0% of portfolio	0	Q4 2024 New
GBIO Generation Bio Co.	$25.4M	$0 0.0% of portfolio	0	Q4 2024 New
GNFT Genfit S.A.	$181M	$0 0.0% of portfolio	0	Q4 2024 New
GERN Geron Corp	$623M	$0 0.0% of portfolio	0	Q4 2024 New
GHRS Gh Research PLC	$575M	$0 0.0% of portfolio	0	Q4 2024 New
GLYC Glycomimetics Inc	$11.5M	$0 0.0% of portfolio	0	Q4 2024 New
GOSS Gossamer Bio, Inc.	$110M	$0 0.0% of portfolio	0	Q4 2024 New
GRAY Graybug Vision, Inc.	$63.5M	$0 0.0% of portfolio	0	Q4 2024 New
GLSI Greenwich Life Sciences, Inc.	$134M	$0 0.0% of portfolio	0	Q4 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$1.96B	$0 0.0% of portfolio	0	Q4 2024 New
HCWB Hcw Biologics Inc.	$10.7M	$0 0.0% of portfolio	0	Q4 2024 New
HLVX Hille Vax, Inc.	$53.1M	$0 0.0% of portfolio	0	Q4 2024 New
IMAB I Mab	$69.8M	$0 0.0% of portfolio	0	Q4 2024 New
IDYA Ideaya Biosciences, Inc.	$820M	$0 0.0% of portfolio	0	Q4 2024 New
IDRA Idera Pharmaceuticals, Inc.	$188M	$0 0.0% of portfolio	0	Q4 2024 New
IGMS Igm Biosciences, Inc.	$35.9M	$0 0.0% of portfolio	0	Q4 2024 New
IKNA Ikena Oncology, Inc.	$47.9M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.